These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 6120985
1. Thyroid-stimulating antibodies in Grave's disease and the effect of thyrotrophin-binding globulins on their determination. Bíró J. J Endocrinol; 1982 Feb; 92(2):175-84. PubMed ID: 6120985 [Abstract] [Full Text] [Related]
2. TSH binding by globulins from patients with Graves' disease. Bíró J. Endocrinol Exp; 1981 Feb; 15(2):145-53. PubMed ID: 6114853 [Abstract] [Full Text] [Related]
3. Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. Orgiazzi J, Williams DE, Chopra IJ, Solomon DH. J Clin Endocrinol Metab; 1976 Feb; 42(2):341-54. PubMed ID: 946604 [Abstract] [Full Text] [Related]
5. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor. Macchia E, Concetti R, Carone G, Borgoni F, Fenzi GF, Pinchera A. Clin Endocrinol (Oxf); 1988 Feb; 28(2):147-56. PubMed ID: 2901922 [Abstract] [Full Text] [Related]
9. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease. Loeffler M, Zakarija M, McKenzie JM. J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706 [Abstract] [Full Text] [Related]
11. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Kosugi S, Ban T, Akamizu T, Kohn LD. Mol Endocrinol; 1992 Feb; 6(2):168-80. PubMed ID: 1349156 [Abstract] [Full Text] [Related]
12. TSH and thyroid stimulating antibodies (TSAb) activate thyroid adenylate cyclase through different pathways. Madsen SN, Bech K. Acta Med Scand Suppl; 1979 Feb; 624():35-42. PubMed ID: 284712 [Abstract] [Full Text] [Related]
13. Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. Laurent E, Van Sande J, Ludgate M, Corvilain B, Rocmans P, Dumont JE, Mockel J. J Clin Invest; 1991 May; 87(5):1634-42. PubMed ID: 1673689 [Abstract] [Full Text] [Related]
14. The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. Kosugi S, Akamizu T, Takai O, Prabhakar BS, Kohn LD. Thyroid; 1991 May; 1(4):321-30. PubMed ID: 1726785 [Abstract] [Full Text] [Related]
15. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment. Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T. J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399 [Abstract] [Full Text] [Related]
20. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T. Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]